Keyphrases
Glioblastoma
100%
Glioma
76%
Tumor
40%
Glioblastoma multiforme
32%
Tumor Microenvironment
23%
Macrophages
22%
Microglia
21%
EGFRvIII
19%
Immunosuppression
18%
Clinical Trials
18%
Signal Transducer and Activator of Transcription 3
17%
Malignant Glioma
17%
Central Nervous System
16%
T Cells
14%
Glioma Patients
14%
Brain Tumor
14%
Human Glioma
14%
Brain Metastases
13%
Temozolomide
13%
Immune Suppression
12%
Glioma Stem Cells
12%
Programmed Death-ligand 1 (PD-L1)
12%
Tumor Cells
12%
Chimeric Antigen Receptor T Cells (CAR-T)
11%
Immune Response
11%
Melanoma
10%
Immune Therapeutics
10%
Tumor Progression
10%
Glioma Microenvironment
9%
Epidermal Growth Factor Receptor
9%
Immune Checkpoint Blockade
9%
Immune Regulation
9%
Murine Model
9%
Immunotherapeutics
9%
Immune Cells
9%
Myeloid Cells
8%
Meningioma
8%
CD8+ T Cells
8%
Therapeutic Efficacy
8%
Primary Brain Tumor
8%
High-grade Glioma
7%
Immune System
7%
Malignancy
7%
Fibrinogen-like Protein 2
7%
WP1066
7%
Central Nervous System Tumors
7%
Therapeutic Target
7%
Therapeutic Potential
7%
Cancer Cells
7%
Regulatory T Cells
7%
Medicine and Dentistry
Glioblastoma
76%
Ganglioglioma
62%
Neoplasm
53%
Immunotherapy
34%
Immunity
32%
Intracranial Tumor
17%
T Cell
17%
Malignant Neoplasm
17%
STAT3 Protein
17%
Immunosuppressive Treatment
16%
Melanoma
15%
Tumor Microenvironment
14%
Brain Metastasis
14%
Epidermal Growth Factor Receptor
13%
Central Nervous System
12%
Metastatic Carcinoma
12%
Macrophage
11%
Clinical Trial
11%
Tumor Progression
9%
Microglia
8%
Diseases
8%
Central Nervous System Tumor
8%
Tumor Cell
7%
Immunosuppressive Drug
7%
Temozolomide
7%
Surgery
7%
Fibrinogen
7%
Chimeric Antigen Receptor T-Cell
6%
Regulatory T Cell
6%
Immunocompetent Cell
6%
Cytotoxic T-Cell
6%
Blood Brain Barrier
6%
Immune Checkpoint Blockade
5%
Neuro-Oncology
5%
Cancer
5%
Metastatic Melanoma
5%
3 (6 Bromo 2 Pyridinyl) 2 Cyano N (1 Phenylethyl)acrylamide
5%
Overall Survival
5%
Specific Tumor
5%
Meningioma
5%
Combination Therapy
5%
Immunology
5%
Immunology and Microbiology
Immunity
66%
Immunotherapy
41%
Macrophage
33%
T Cell
25%
Microglia
22%
Immunosuppression
19%
Central Nervous System
16%
STAT3
16%
Immunosuppressive Drug
16%
Myeloid
14%
Regulatory T Cell
13%
Tumor Cell
13%
Immunocompetent Cell
13%
Epidermal Growth Factor
12%
Immune Response
12%
Fibrinogen
9%
Cancer Cell
9%
Cytotoxic T-Cell
8%
Overall Survival
8%
Cytokine
7%
Cancer Stem Cell
7%
Immunology
6%
Immune System
6%
Dendritic Cell
6%
CD8
6%
Immunomodulation
5%
Syngenic
5%
Lymphocytopenia
5%